Prof. Dr. Rainer Fietkau

Medizinische Fakultät Lehrstuhl für Strahlentherapie

Cetuximab in combination with platinum-based chemotherapy or radiotherapy in recurent and/or metastatic SCCHN in a non-selected patient cohort (interim analysis of the phase IV SOCCER trial) (2016) Hecht M, Hahn D, Beutner D, Reichert D, Goehler T, Wurm R, Welslau M, et al. Conference contribution Tumor infiltrating cells - cell-to-cell distances enable differentiation between functionally active and suppressed inflammatory cells (2016) Distel L, Nagl S, Fietkau R, Haas M Conference contribution The Treatment Reality of Octogenarians with Bladder Cancer in a Maximum Care Hospital (2016) Sikic D, Wach S, Taubert H, Richterstetter M, Kunath F, Lieb V, Krause S, et al. Conference contribution Temozolomide resistance in human glioblastoma cell line U251 is caused by mismatch repair deficiency and can be overcome by lomustine (2016) Stritzelberger J, Distel T, Fietkau R, Putz F Conference contribution THE IMPACT OF LOW-DOSE RADIATION ON INFLAMMATORY DISEASES (2016) Deloch L, Derer A, Hueber A, Fietkau R, Frey B, Gaipl U Conference contribution Oral cavity carcinomas as primary manifestation of telomere maintenance disorders (telomeropathies) (2016) Beier F, Schmitt K, Bouillon AS, Hasenbank C, Vankann L, Ambrosch P, Hoffmann T, et al. Conference contribution Investigating a Correlation between Chemoradiotherapy Schedule Parameters and Overall Survival in a real-life LD SCLC Patient Cohort (2016) Manapov F, Eze C, Niyazi M, Roengvoraphoj O, Li M, Hegemann NS, Hildebrandt G, et al. Journal article Improved survival for elderly married glioblastoma patients : Better treatment delivery, less toxicity, and fewer disease complications (2016) Putz F, Putz T, Goerig N, Knippen S, Gryc T, Eyüpoglu IY, Roessler K, et al. Journal article Interstitial brachytherapy as a boost to patients with anal carcinoma and poor response to chemoradiation: Single-institution long-term results (2016) Gryc T, Ott O, Putz F, Knippen S, Raptis D, Fietkau R, Strnad V Journal article GEC-ESTRO multicenter phase 3-trial: Accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: Early toxicity and patient compliance (2016) Ott O, Strnad V, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, Lyczek J, et al. Journal article